Three more years for partnership between Varian and MedAssets:
This article was originally published in Clinica
Palo Alto, California-based Varian Medical Systems has renewed its contract with MedAssets Supply Chain Systems, agreeing to supply the US group purchasing organisation with its cancer therapy systems for another three years. The contract covers Varian's full range of products, including capital equipment and software, for delivering radiotherapy and neurosurgery.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.